miRquad: first-in-class dPCR multiplex TaqMan™ Advanced clinical research assay for microRNA detection in head and neck cancer

The assay overcomes common challenges associated with multiple miRNAs detection, particularly in liquid biopsy samples (e.g., multiple pipetting issues, increased consumption of sample for multiple assessment, extended TAT for complete profiling) and provides robust and accurate detection, demonstrating potential for real-time patient monitoring and prognostication in HNC.

Authors

Institutions

Publication Details

Journal
Journal of Experimental & Clinical Cancer Research
Published
2025-12-20
DOI
https://doi.org/10.1186/s13046-025-03590-6
Primary Topic
MicroRNA in disease regulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

miRquad: first-in-class dPCR multiplex TaqMan™ Advanced clinical research assay for microRNA detection in head and neck cancer

Stella Gagliardi, Eloisa Arbustini, Stefano Ferrero, Federica Ganci et al.
Journal of Experimental & Clinical Cancer Research
MicroRNA in disease regulation
article

miRquad: first-in-class dPCR multiplex TaqMan™ Advanced clinical research assay for microRNA detection in head and neck cancer

Stella Gagliardi, Eloisa Arbustini, Stefano Ferrero, Federica Ganci, Roberta Maestro, Antonio Pisani, Matteo Allegretti, David Joun, Junko Stevens, Alfredo Budillon, Valentina De Pascale, Simona De Summa, Tania Moccia, Giovanni Blandino, Luca Sigalotti, Elena Di Gennaro, Amalia Azzariti, Gennaro Ciliberto, Paola C. Muti, Chiara Ciardiello, Giada Anna Beltramini, Mario Urtis, Raul Pellini, G Urbani, Stefano Fiori
article en

Abstract

The assay overcomes common challenges associated with multiple miRNAs detection, particularly in liquid biopsy samples (e.g., multiple pipetting issues, increased consumption of sample for multiple assessment, extended TAT for complete profiling) and provides robust and accurate detection, demonstrating potential for real-time patient monitoring and prognostication in HNC.

Journal of Experimental & Clinical Cancer ResearchVol. 45(1)
University of Milan (IT), University of Pavia (IT), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), Centro di Riferimento Oncologico (IT), Istituto Tumori Bari (IT), National Cancer Institute (MY), Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (IT), Thermo Fisher Scientific (United States) (US), Policlinico San Matteo Fondazione (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Openalex Percentile: Top 50%
MicroRNA in disease regulation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.